NIH授予New England Biolabs64万美元资助其表观遗传学工具开发
- 互联网2012年11月12日 21:48 点击：1417
纽英仑实验室（New England Biolabs）周四宣布，他们已经收到来自美国国立卫生研究院的第二阶段小企业创新资助，共计64万美元。用于扩大其表观遗传学工具的研发。
NIH Grants New England Biolabs $640K for Epigenetic Tools Development
NEW YORK (GenomeWeb News) – New England Biolabs announced Thursday that it has received a $640,000 Phase II Small Business Innovation grant from the National Institutes of Health to expand its research into development of enzymatic tools for epigenetic analysis.
The Ipswich, Mass.-based company said it has focused on using restriction enzymes in epigenetic studies for years, and research into methylation-dependent and methylation-sensitive restriction enzymes has resulted in new tools for identifying such DNA modifications. The grant announced today will enable additional research into this area, resulting in "a deeper understanding of epigenetic marks in the mammalian genome."
In 2010 New England Biolabs received an SBIR grant for $1.2 million for research into and the development of enzymatic reagents for epigenetics. It said today that it has received more than $1.1 million in SBIR funds since 2009.
联系邮箱：kefu@labbase.net
版权与免责声明
- 凡本网注明“来源：来宝网”的所有作品，版权均属于来宝网，转载请必须注明来宝网， http://www.labbase.net，违反者本网将追究相关法律责任。
- 本网转载并注明自其它来源的作品，目的在于传递更多信息，并不代表本网赞同其观点或证实其内容的真实性，不承担此类作品侵权行为的直接责任及连带责任。其他媒体、网站或个人从本网转载时，必须保留本网注明的作品来源，并自负版权等法律责任。
- 如涉及作品内容、版权等问题，请在作品发表之日起一周内与本网联系，否则视为放弃相关权利。
